Back to Immunity
SupplementPreliminary evidenceImmunity

Boron

Trace mineral with preliminary evidence for bone, joint, and hormone-modulating effects, no EFSA-authorised claim; safety considerations at high doses.

Why

Boron is a trace mineral with preliminary evidence for effects on bone density, joint pain, and steroid hormone metabolism. EFSA has not authorised a specific health claim, but several mechanistic studies and small trials (Nielsen 1987, Travers 1990, Pizzorno 2015) suggest benefit in postmenopausal bone and OA. EU has set a tolerable upper intake level of 10 mg/day; reproductive toxicity at higher chronic doses is documented in animal studies.

How it works

Modulates steroid hormone metabolism, small RCTs report increased free testosterone and oestradiol in deficient adults. Cofactor for hydroxylation of vitamin D and steroid hormones. Anti-inflammatory effects in joint tissue.

Expected onset · Bone-marker changes over months; hormone effects within 4–6 weeks (when present)

How to take

Dosage

3–10 mg/day. Stay well within the EU upper limit of 10 mg/day.

Timing

Once daily with food

On the label

Boron citrate, glycinate, or aspartate. Stated elemental boron per dose. Some products combine with calcium and magnesium for bone formulas.

Ideal for

Adults with osteopaenia/osteoporosis or osteoarthritis seeking nutrient-mineral adjuncts under guidance, staying well within the safety upper limit.

Safety

Animal reproductive toxicity at chronic high doses, EU has set a 10 mg/day upper limit. Avoid in pregnancy and breastfeeding (limited human data). Hormone-modulating effect may interact with hormonal therapies and oestrogen-sensitive conditions.

Evidence

At a glance

Nielsen 1987 FASEB J open trial: boron repletion in deficient postmenopausal women increased serum oestradiol and ionised calcium retention. Preliminary, RCTs exist in non-tier-1 journals but are small or short-duration. No Cochrane review, EMA monograph or EFSA-authorised claim covers the indication.

Limitations

Preliminary, RCTs exist in non-tier-1 journals but are small or short-duration. No Cochrane review, EMA monograph or EFSA-authorised claim covers the indication.

Where to get it

Shop Boron on Amazon

Sponsored · As an Amazon Associate, Healicus earns from qualifying purchases.